Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Scientific Reports|March 5, 2020
CTLA-4 blockade boosts the expansion of tumor-reactive CD8<sup>+</sup> tumor-infiltrating lymphocytes in ovarian cancerChristina Friese, Katja Harbst, Troels Holz Borch, et al.
British Journal of Cancer|March 21, 2019
Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancerMarie Christine Wulff Westergaard, Rikke Andersen, Chloé Chong, et al.
British Journal of Cancer|February 6, 2019
Tumour-reactive T cell subsets in the microenvironment of ovarian cancerMarie Christine Wulff Westergaard, Rikke Andersen, Chloé Chong, et al.
Cancer Immunology Research|January 6, 2018
T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell TherapyRikke Andersen, Marie Christine Wulff Westergaard, Julie Westerlin Kjeldsen, et al.
Cancer Immunology, Immunotherapy : CII|July 17, 2021
Transcriptomic signatures of tumors undergoing T cell attackAishwarya Gokuldass, Aimilia Schina, Martin Lauss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
PD-1<sup>+</sup> Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for CancerMarco Donia, Julie Westerlin Kjeldsen, Rikke Andersen, et al.
Oncotarget|June 18, 2020
Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancerAnders Handrup Kverneland, Magnus Pedersen, Marie Christine Wulff Westergaard, et al.
Oncoimmunology|December 8, 2018
Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot studyMagnus Pedersen, Marie Christine Wulff Westergaard, Katy Milne, et al.
Cancers|December 23, 2020
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian CancerMarie Christine Wulff Westergaard, Katy Milne, Magnus Pedersen, et al.
Pageof 5